Dyadic Applied BioSolutions partners with IBT Bioservices for distribution
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
March 16, 2026 7:20 AM EDTJUPITER, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (Dyadic, we, us, our, or the Company) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life science, food and nutrition, and bioindustrial applications today announced that it has entered into an original equipment manufacturer (OEM) distribution agreement with Integrated Biotherapeutics, LLC, d/b/a IBT Bioservices (IBT), a life sciences reagent manufacturer and distributor serving global research markets. Through this collaboration, Dyadic-produced recombinant protein products will be commercialized through IBTs established sales channels, expanding market access and supporting Dyadics objective of generating ongoing, product-based... More
